View Single Post
  #1  
Old Sun Jan 2, 2011, 04:23 PM
akita akita is offline
Member
 
Join Date: Nov 2010
Posts: 110
Expanded Access to investigational Drugs for Treatment Use

How can i get a permit for extended access to drugs who are not yet approved by the FDA? This is possible in the cases described in the different documents, listed in this thread.

If the FDA says yes, the other question: who pays for the drug, must be solved. Medicaid does not pay for it. As to read in the discussions indicated in the legal documents 4. and 5., it was supposed that people with low income should get the drugs for free as some drug oompanies perhaps give them for free to some sort of needy people. Perhaps there are special funds that help you. Maybe not successfull applying there, maybe an illusion..?

But beside the cost of drugs are expenses also for the doctor who has to come in for the FDA-special permission for the adminmistration. By law rules the drugproviding company can decide freely if it would give the drug for extended use. The treating doctor is fully responsible for the treatment, the patient must provide informed consent. In the documents and informations you can read more detail. In addition it is possible to learn more by free webinars provided by ASCO.

If somebody has special questions, i hope that i or anybody else in the forum can answer them.

Practically it would cause a lot of paper-work for applying to that extended use e.g. for Nplate for an individual person in emergency health situationö. One must consider the special local situation in the treating center, who makes the treatment decisions, where are the patients data needed for the application stored, how can they be approached.. etc. (for example: When i want to get my datas, i have to apply to a special Center in vienna which organizes that. Patients datas 1 year old oder older are not stored in the ward or ambulance any more.. And you need perhaps such datas for argumentation, that your disease and treatment history demands the special medication now..).

In the appendix of this posting you find the mentioned links.

Hope i can help,

Margarete


----------------

1. IDE Early / extended access

http://www.fda.gov/MedicalDevices/De.../ucm051345.htm

2.Information for Consumers: Access to Investigational Drugs

http://www.fda.gov/ForConsumers/ByAu...gs/default.htm

3. Physician Request for an Individual Patient IND under Expanded Access for Non-emergency or Emergency Use

http://www.fda.gov/Drugs/Development.../ucm107434.htm

4. Expanded Access Training Webinar

http://www.fda.gov/ForConsumers/ByAu.../ucm217583.htm

Legal Materials:

5. http://edocket.access.gpo.gov/2009/pdf/E9-19005.pdf

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 312 and 316
[Docket No. FDA–2006–N–0238] (formerly Docket No. 2006N–0062)
RIN 0910–AF14

Expanded Access to Investigational Drugs for Treatment Use
AGENCY: Food and Drug Administration,
HHS.
ACTION: Final rule.

6.. http://edocket.access.gpo.gov/2009/pdf/E9-19004.pdf

Register, August 13, 3009 Part II
Department of Health and Human Services
Food and Drug Administration
21 CFR Part 312 and 316

Charging for Investigational Drugs Under
and Investigational New Drug Application;
Expanded Access to Investigational Drugs
for Treatment Use; Final Rules
--------------
__________________
Margarete, 54, living in Vienna, Austria,
MDS/AML M2, diagnosed 9/2007, then Chemos, aSZT 4/2008, chronic GVHD

Last edited by akita : Sun Jan 2, 2011 at 04:35 PM.
Reply With Quote